A new global study has identified striking inequalities in disability caused by COVID-19 during 2020–2021, offering an early warning signal for the ongoing risk of long COVID in the years that followed — and even today. By examining across 920 locations worldwide, researchers found that low- and middle-income countries (LMICs), especially in Sub-Saharan Africa, showed disproportionately high rates of nonfatal COVID-related health loss. These findings highlight potentially hidden vulnerabilities and call for urgent action to address long-term pandemic effects in underserved populations.

Bar-Ilan University has joined a major new €8 million European initiative aimed at revolutionizing how personalized cancer treatments like CAR-T cell therapy are delivered in hospitals. Funded by the EU-backed Innovative Health Initiative (IHI), the five-year project—called EASYGEN (Easy workflow integration for gene therapy)—will develop a fully automated system that allows hospitals to manufacture CAR-T therapies on-site in just 24 hours instead of weeks.

A new study has identified three distinct molecular subtypes of follicular lymphoma (FL), offering insights that may shape future precision diagnostics and personalized treatment plans for patients across Asia and the West.

The research was jointly conducted by scientists at BGI Genomics' Institute of Intelligent Medical Research (IIMR) and Sweden's Karolinska Institutet, published in Cell Reports Medicine early August.